Article
FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia.
Blood - 15 Oct 2006
Pollard Jessica A, Alonzo Todd A, Gerbing Robert B, Woods William G, Lange Beverly J, Sweetser David A, Radich Jerald P, Bernstein Irwin D, Meshinchi Soheil
Abstract excerpt
Acute myeloid leukemia (AML) is a clonal disease characterized by heterogeneous involvement of hematopoietic stem cell/progenitor cell populations. Using FLT3 internal tandem duplication (FLT3/ITD) as a molecular marker, we tested the hypothesis that clinical outcome in AML correlates with disease involvement of CD34(+)/CD33(-) precursors. Diagnostic specimens from 24 children with FLT3/ITD-positive AML were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
